Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Reported, And Analysts Assigned A US$11.67 Price Target [Yahoo! Finance]
Foghorn Therapeutics Inc. (NASDAQ: FHTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update [Yahoo! Finance]
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update